- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/745 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class C07K 14/745
Total number of patents in this class: 700
10-year publication summary
|
57
|
51
|
59
|
59
|
55
|
59
|
27
|
28
|
25
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2943 |
29 |
| The Children's Hospital of Philadelphia | 752 |
17 |
| Modernatx, Inc. | 1206 |
17 |
| Bioverativ Therapeutics Inc. | 213 |
16 |
| Opko Biologics Ltd. | 75 |
12 |
| Gladiator Biosciences, Inc. | 15 |
12 |
| Novo Nordisk Health Care AG | 361 |
11 |
| The University of North Carolina at Chapel Hill | 1998 |
11 |
| Yale University | 2289 |
11 |
| CSL Behring GmbH | 345 |
10 |
| CSL Limited | 254 |
10 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
10 |
| Immunitybio, Inc. | 267 |
9 |
| Alexion Pharmaceuticals, Inc. | 622 |
8 |
| Case Western Reserve University | 1770 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
7 |
| Novo Nordisk Healthcare AG | 34 |
7 |
| Amunix Pharmaceuticals, Inc. | 75 |
7 |
| HCW Biologics, Inc. | 33 |
7 |
| Baxter International Inc. | 2459 |
6 |
| Other owners | 475 |